Moxiva (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxiva, is a fluoroquinolone antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and skin and skin structure infections in adults.

GNH USA supplies Moxiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxiva (moxifloxacin) is indicated for bacterial infections affecting the respiratory tract and skin.

Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical symptoms. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Acute bacterial exacerbation of chronic bronchitis: improves cough and sputum production while preventing disease progression. Skin and skin structure infections: resolves infection and promotes wound healing.

Moxiva may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Headache: transient headache. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: risk of tendon inflammation or rupture. - QT interval prolongation: may cause cardiac arrhythmias. - Severe allergic reaction: includes rash, swelling, or anaphylaxis.

Before prescribing Moxiva, consider the following precautions.

Renal impairment: adjust therapy based on renal function. History of tendon disorders: avoid use due to risk of tendon rupture. Concomitant QT‑prolonging drugs: monitor cardiac rhythm. Pregnancy and lactation: use only if benefits outweigh risks. Hypersensitivity: discontinue if allergic reaction occurs. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Moxiva can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption. - NSAIDs (especially high‑dose): increase risk of CNS stimulation. - Warfarin: may enhance anticoagulant effect. - Cyclosporine: increased serum levels. - Theophylline: increased toxicity.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: higher risk of tendon rupture. - Diabetic agents: may affect glucose control.